The European Society for Medical Oncology and the American Society of Clinical Oncology (ESMO and ASCO)...

Results from a number of highly anticipated phase 3 clinical trials across the range of gynaecological...

Interim results from the phase 2 ENZA-p study (NCT04419402) show that adding 177Lu-PSMA-617 to enzalutamide...

Positive results from the TROPION-Breast01 phase 3 trial showed that a specifically engineered TROP2...

Shared decision-making is more than being attentive to patients’ needs or concerns – it also represents...

A multidisciplinary surgical approach implemented at the Mater Hospital, Dublin, has improved outcomes...

Neurological disorders are currently the second highest cause of death and the leading cause of disability...

A ground-breaking discovery into the mechanisms driving Rett syndrome was unveiled during the 2023 World Congress...

During a plenary lecture at the World Congress of Neurology, Prof Anthony Lang, Professor of Neurology...

ECTRIMS 2023 heard how growing understanding of the pathology and underlying mechanisms of MS...

An overview of the key changes in the National Clinical Guideline for Stroke for the UK...

The largest genetic study of epilepsy to date provides new insights on why epilepsy develops and...